Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality

Author:

Karageorgou Vagia1,Papaioannou Andriana I.2ORCID,Kallieri Maria1,Blizou Myrto1,Lampadakis Stefanos1,Sfika Maria1,Krouskos Antonios1ORCID,Papavasileiou Vasileios1ORCID,Strakosha Franceska1,Vandorou Kalliopi Theoni1,Siozos Pavlos1,Moustaka Christodoulou Marina1,Kontonasiou Georgia1,Apollonatou Vasiliki1ORCID,Antonogiannaki Elvira Markella3,Kyriakopoulos Christos4ORCID,Aggelopoulou Christina4,Chronis Christos4,Kostikas Konstantinos4ORCID,Koukaki Evangelia2ORCID,Sotiropoulou Zoi2,Athanasopoulou Athanasia2,Bakakos Petros2ORCID,Schoini Pinelopi3,Alevrakis Emmanouil3ORCID,Poupos Sotirios3,Chondrou Evangelia3,Tsoukalas Dionisios3,Chronaiou Alexia3,Tsoukalas George3,Koukidou Sofia5ORCID,Hillas Georgios5,Dimakou Katerina5,Roukas Konstantinos6,Nakou Ifigeneia6,Chloros Diamantis6,Fouka Evangelia6ORCID,Papiris Spyros A.1,Loukides Stelios1ORCID

Affiliation:

1. 2nd Respiratory Medicine Department, “Attikon” University Hospital, Athens Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece

2. 1st Respiratory Medicine Department, “Sotiria” Chest Hospital, Athens Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece

3. 4th Respiratory Medicine Department, “Sotiria” Chest Hospital, 11527 Athens, Greece

4. Respiratory Medicine Department, University Hospital of Ioannina, 45500 Ioannina, Greece

5. 5th Respiratory Medicine Department, “Sotiria” Chest Hospital, 11527 Athens, Greece

6. COVID-19 Clinic, General Hospital G. Papanikolaou, Aristotle University of Thessaloniki, 57010 Thessaloniki, Greece

Abstract

Background: Coronavirus disease 2019 (COVID-19) has been a pandemic since 2020, and depending on the SARS-CoV-2 mutation, different pandemic waves have been observed. The aim of this study was to compare the baseline characteristics of patients in two phases of the pandemic and evaluate possible predictors of mortality. Methods: This is a retrospective multicenter observational study that included patients with COVID-19 in 4 different centers in Greece. Patients were divided into two groups depending on the period during which they were infected during the Delta and Omicron variant predominance. Results: A total of 979 patients (433 Delta, 546 Omicron) were included in the study (median age 67 years (54, 81); 452 [46.2%] female). Compared to the Omicron period, the patients during the Delta period were younger (median age [IQR] 65 [51, 77] vs. 70 [55, 83] years, p < 0.001) and required a longer duration of hospitalization (8 [6, 13] vs. 7 [5, 12] days, p = 0.001), had higher procalcitonin levels (ng/mL): 0.08 [0.05, 0.17] vs. 0.06 [0.02, 0.16], p = 0.005, ferritin levels (ng/mL): 301 [159, 644] vs. 239 [128, 473], p = 0.002, C- reactive protein levels (mg/L): 40.4 [16.7, 98.5] vs. 31.8 [11.9, 81.7], p = 0.003, and lactate dehydrogenase levels (U/L): 277 [221, 375] vs. 255 [205, 329], p < 0.001. The Charlson Comorbidity Index was lower (3 [0, 5] vs. 4 [1, 6], p < 0.001), and the extent of disease on computed tomography (CT) was greater during the Delta wave (p < 0.001). No evidence of a difference in risk of death or admission to the intensive care unit was found between the two groups. Age, cardiovascular events, acute kidney injury during hospitalization, extent of disease on chest CT, D-dimer, and neutrophil/lymphocyte ratio values were identified as independent predictors of mortality for patients in the Delta period. Cardiovascular events and acute liver injury during hospitalization and the PaO2/FiO2 ratio on admission were identified as independent predictors of mortality for patients in the Omicron period. Conclusions: In the Omicron wave, patients were older with a higher number of comorbidities, but patients with the Delta variant had more severe disease and a longer duration of hospitalization.

Publisher

MDPI AG

Subject

General Medicine

Reference50 articles.

1. (2023, July 10). World Health Organization Director-General’s Opening Remarks at the Media Briefing on COVID-19-11 March 2020. Available online: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

3. COVID-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction;Mahase;BMJ,2020

4. (2023, July 14). WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int/.

5. Aleem, A., Akbar Samad, A.B., and Vaqar, S. (2023). Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19), StatPearls Publishing.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3